Clene Provides Update on ALS Clinical Development Meeting With FDA
Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA| (NASDAQ: CLNN) | Delayed: 4.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.99 | 52 Week High | $ | |||
| Open | $4.99 | 52 Week Low | $ | |||
| Day High | $4.99 | P/E | N/A | |||
| Day Low | $4.99 | EPS | $ | |||
| Volume | 5,315 | |||||
